by Master | Sep 8, 2025 | RF Treatments
EMFACE Now FDA‑Cleared for TMJ Dysfunction In August 2025, BTL Industries announced that its device EMFACE® has received a new indication from the U.S. Food and Drug Administration (FDA) for the treatment of temporomandibular joint (TMJ) dysfunction. In addition to...
